This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 1992 Jul 2;358(6381):15-6.

doi: 10.1038/358015a0.

Cancer. p53, guardian of the genome

D P Lane

PMID: 1614522
DOI: 10.1038/358015a0

Comment

Cancer. p53, guardian of the genome

D P Lane. Nature. 1992.

. 1992 Jul 2;358(6381):15-6.

doi: 10.1038/358015a0.

Author

D P Lane

PMID: 1614522
DOI: 10.1038/358015a0

No abstract available

PubMed Disclaimer

Comment in

Checkpoint policing by p53.
Carr AM, Green MH, Lehmann AR. Carr AM, et al. Nature. 1992 Oct 8;359(6395):486-7. doi: 10.1038/359486a0. Nature. 1992. PMID: 1406967 No abstract available.

Comment on

Amplification of a gene encoding a p53-associated protein in human sarcomas.
Oliner JD, Kinzler KW, Meltzer PS, George DL, Vogelstein B. Oliner JD, et al. Nature. 1992 Jul 2;358(6381):80-3. doi: 10.1038/358080a0. Nature. 1992. PMID: 1614537
Wild-type p53 activates transcription in vitro.
Farmer G, Bargonetti J, Zhu H, Friedman P, Prywes R, Prives C. Farmer G, et al. Nature. 1992 Jul 2;358(6381):83-6. doi: 10.1038/358083a0. Nature. 1992. PMID: 1614538

Similar articles

Transcription factors Oct-1 and NF-YA regulate the p53-independent induction of the GADD45 following DNA damage.
Jin S, Fan F, Fan W, Zhao H, Tong T, Blanck P, Alomo I, Rajasekaran B, Zhan Q. Jin S, et al. Oncogene. 2001 May 10;20(21):2683-90. doi: 10.1038/sj.onc.1204390. Oncogene. 2001. PMID: 11420680
Identification of BTG2, an antiproliferative p53-dependent component of the DNA damage cellular response pathway.
Rouault JP, Falette N, Guéhenneux F, Guillot C, Rimokh R, Wang Q, Berthet C, Moyret-Lalle C, Savatier P, Pain B, Shaw P, Berger R, Samarut J, Magaud JP, Ozturk M, Samarut C, Puisieux A. Rouault JP, et al. Nat Genet. 1996 Dec;14(4):482-6. doi: 10.1038/ng1296-482. Nat Genet. 1996. PMID: 8944033
Regulation of DNA damage recognition and nucleotide excision repair: another role for p53.
Ford JM. Ford JM. Mutat Res. 2005 Sep 4;577(1-2):195-202. doi: 10.1016/j.mrfmmm.2005.04.005. Mutat Res. 2005. PMID: 15927209 Review.
Global genome repair is required to activate KIN17, a UVC-responsive gene involved in DNA replication.
Masson C, Menaa F, Pinon-Lataillade G, Frobert Y, Chevillard S, Radicella JP, Sarasin A, Angulo JF. Masson C, et al. Proc Natl Acad Sci U S A. 2003 Jan 21;100(2):616-21. doi: 10.1073/pnas.0236176100. Epub 2003 Jan 13. Proc Natl Acad Sci U S A. 2003. PMID: 12525703 Free PMC article.
[Tumor suppressor gene p53--function and significance in gastroenterology].
Schoppmeyer K, Keim V, Mössner J. Schoppmeyer K, et al. Z Gastroenterol. 1997 Jun;35(6):491-509. Z Gastroenterol. 1997. PMID: 9281241 Review. German.

See all similar articles

Cited by

Multiscale simulations reveal the driving forces of p53C phase separation accelerated by oncogenic mutations.
Yu Y, Liu Q, Zeng J, Tan Y, Tang Y, Wei G. Yu Y, et al. Chem Sci. 2024 Jul 15;15(32):12806-12818. doi: 10.1039/d4sc03645j. eCollection 2024 Aug 14. Chem Sci. 2024. PMID: 39148776 Free PMC article.
Prognostic and Therapeutic Implications of Cell Division Cycle 20 Homolog in Breast Cancer.
Messeha SS, Zarmouh NO, Maku H, Gendy S, Yedjou CG, Elhag R, Latinwo L, Odewumi C, Soliman KFA. Messeha SS, et al. Cancers (Basel). 2024 Jul 15;16(14):2546. doi: 10.3390/cancers16142546. Cancers (Basel). 2024. PMID: 39061186 Free PMC article.
Evaluation of a Covalent Library of Diverse Warheads (CovLib) Binding to JNK3, USP7, or p53.
Klett T, Schwer M, Ernst LN, Engelhardt MU, Jaag SJ, Masberg B, Knappe C, Lämmerhofer M, Gehringer M, Boeckler FM. Klett T, et al. Drug Des Devel Ther. 2024 Jul 1;18:2653-2679. doi: 10.2147/DDDT.S466829. eCollection 2024. Drug Des Devel Ther. 2024. PMID: 38974119 Free PMC article.
MDM2/MDMX inhibition by Sulanemadlin synergizes with anti-Programmed Death 1 immunotherapy in wild-type p53 tumors.
Ingelshed K, Melssen MM, Kannan P, Chandramohan A, Partridge AW, Jiang L, Wermeling F, Lane DP, Nestor M, Spiegelberg D. Ingelshed K, et al. iScience. 2024 May 6;27(6):109862. doi: 10.1016/j.isci.2024.109862. eCollection 2024 Jun 21. iScience. 2024. PMID: 38784022 Free PMC article.
Tumor biomarkers for diagnosis, prognosis and targeted therapy.
Zhou Y, Tao L, Qiu J, Xu J, Yang X, Zhang Y, Tian X, Guan X, Cen X, Zhao Y. Zhou Y, et al. Signal Transduct Target Ther. 2024 May 20;9(1):132. doi: 10.1038/s41392-024-01823-2. Signal Transduct Target Ther. 2024. PMID: 38763973 Free PMC article. Review.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
Other Literature Sources
- The Lens - Patent Citations
Research Materials
- NCI CPTC Antibody Characterization Program
Miscellaneous
- NCI CPTAC Assay Portal

-